Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations. [electronic resource]
Producer: 20160112Description: 358-67 p. digitalISSN:- 2159-8290
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Colorectal Neoplasms -- diagnosis
- Drug Resistance, Neoplasm -- drug effects
- ErbB Receptors -- antagonists & inhibitors
- Gene Amplification
- Humans
- MAP Kinase Kinase 1 -- genetics
- MAP Kinase Signaling System -- drug effects
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Mutation
- Oncogene Protein p21(ras) -- genetics
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Transcriptional Activation
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.